EUVIMEDEUVIMED entdecken
Crossref

Depletion of ELMOD3 inhibits the growth and migration of gastric cancer cells by disrupting the β‐catenin signaling and the F‐actin cytoskeleton

Pengli Guo iD, Chentong Xu iD, Xuan Zhang iD, Jinqiu Feng iD, Yaxin Lou iD, Shufang Ye iD, Ping Lv iD, Bin Zhu iD, Yingyu Chen iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202400833rrr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Pengli Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Peking University School of Basic Medical Sciences; NHC Key Laboratory of Medical Immunology, Peking University, Beijing, C…. Hauptthemen laut MEDLINE: Stomach Neoplasms, beta Catenin, Cell Movement, Cell Proliferation. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Key Support Project of Guo Zhong Health Care of China General Technology Group, National natural Science Foudation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ELMOD3 (encoding ELMO domain containing 3) is a causative gene associated with human autosomal dominant nonsyndromic and progressive hearing loss. However, the role of ELMOD3 in the occurrence and development of tumors remains unknown. Herein, we observed that inactivation of ELMOD3 in gastric cancer cells significantly inhibited their proliferation, migration, and invasion, and altered cell cycle progression. A xenograft tumor model showed that knockout of ELMOD3 suppressed the tumorigenicity of BGC823 gastric cancer cells in nude mice. Further investigation demonstrated that the ELMO domain of ELMOD3 interacts with β‐catenin, which increases the levels of β‐catenin, promoting downstream target gene expression. Deletion of ELMOD3 in gastric cells decreased the β‐catenin signaling, elevated E‐cadherin levels, suppressed RAF/MEK/ERK signal pathway, and disrupted the formation of F‐actin cytoskeleton. These results led us to propose that ELMOD3 may participate in multiple biological processes in promoting the tumorigenesis of gastric cancer. It exerts a positive role in the regulation of gastric cancer cell proliferation and progression. Thus, ELMOD3 was identified as a potential tumor target, which deserves further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach Neoplasmsbeta CateninCell MovementCell ProliferationActin CytoskeletonMice, NudeHumansAnimalsMiceCell Line, TumorSignal TransductionMice, Inbred BALB CGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ELMOD3cell growthgastric cancermigrationβ‐Catenin/CTNNB1

Substanzen

beta CateninCTNNB1 protein, human

Autor:innen und Institutionen

  • Department of Immunology, Peking University School of Basic Medical Sciences; NHC Key Laboratory of Medical Immunology, Peking University, Beijing, China.
  • Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Beijing Pediatric Research Institute, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Department of General Surgery, Beijing Electric Power Hospital, State Grid Corporation of China, Key Laboratory of Geriatrics (Hepatobiliary Diseases) of China General Technology Group, Beijing, China.
  • Medical and Healthy Analytical Center, Peking University, Beijing, China.
  • Department of Orthopaedics, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Center for Human Disease Genomics, Peking University, Beijing, China.

ORCID-Profile: Pengli Guo, Chentong Xu, Xuan Zhang, Jinqiu Feng, Yaxin Lou, Shufang Ye, Ping Lv, Bin Zhu, Yingyu Chen

Förderung

  • Key Support Project of Guo Zhong Health Care of China General Technology Group
  • National natural Science Foudation of China

Zitieren

APA

Guo, P., Xu, C., Zhang, X., Feng, J., Lou, Y., Ye, S., Lv, P., Zhu, B., & Chen, Y. (2024). Depletion of ELMOD3 inhibits the growth and migration of gastric cancer cells by disrupting the β‐catenin signaling and the F‐actin cytoskeleton. The FASEB Journal. https://doi.org/10.1096/fj.202400833rrr

Vancouver

Guo P, Xu C, Zhang X, Feng J, Lou Y, Ye S, et al. Depletion of ELMOD3 inhibits the growth and migration of gastric cancer cells by disrupting the β‐catenin signaling and the F‐actin cytoskeleton. The FASEB Journal. 2024. doi:10.1096/fj.202400833rrr

BibTeX
@article{Guo2024,
  author = {Guo, Pengli and Xu, Chentong and Zhang, Xuan and Feng, Jinqiu and Lou, Yaxin and Ye, Shufang and Lv, Ping and Zhu, Bin and Chen, Yingyu},
  title = {Depletion of ELMOD3 inhibits the growth and migration of gastric cancer cells by disrupting the β‐catenin signaling and the F‐actin cytoskeleton},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202400833rrr}
}
Kostenlos starten →